Company Overview
SERES THERAPEUTICS, INC.
MCRBRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1M
2025 FY
Net Income
6M
2025 FY
Shares Outstanding
9M
2025 FY
EPS
0.64USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1609809
Exchange
Nasdaq
Location
US